Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

Inclusion Criteria: * Ages eligible for study : 18 years to 74 years * Genders eligible for study : Male and Female * Diagnosed with T2DM * Taking a stable dose of metformin monotherapy * HbA1c levels of between ≥ 7.0% and ≤ 10.0% * Females of childbearing potential who are not pregnant and agree to use a reliable method of birth control * Written informed consent must be obtained Exclusion Criteria: * Pregnant or nursing (lactating) women * Diagnosis of type 1 diabetes mellitus * Uncontrolled diabetes defined as a FPG level of \> 240 mg/dL at screening * A significant change in body weight in the 3 months before screening * Any history of GI intolerance * Personal or family history of medullary thyroid cancer (MTC) or a genetic condition that predisposes to MTC * Known history of acute or chronic pancreatitis * A history of alcohol or drug abuse or drug addiction